|
|
|||||||
| |||||||
| |||||||
| 1 | AN ACT concerning aging.
| ||||||
| 2 | Be it enacted by the People of the State of Illinois,
| ||||||
| 3 | represented in the General Assembly:
| ||||||
| 4 | Section 5. The Senior Pharmaceutical Assistance Act is | ||||||
| 5 | amended by changing Section 15 as follows: | ||||||
| 6 | (320 ILCS 50/15)
| ||||||
| 7 | Sec. 15. Senior Pharmaceutical Assistance Review | ||||||
| 8 | Committee.
| ||||||
| 9 | (a) The Senior Pharmaceutical Assistance Review Committee | ||||||
| 10 | is
created. The Committee shall consist of 17 members as | ||||||
| 11 | follows:
| ||||||
| 12 | (1) Twelve members appointed as follows: 2 members of | ||||||
| 13 | the General
Assembly and 1 member of the general public, | ||||||
| 14 | appointed by the President of the
Senate; 2 members of the | ||||||
| 15 | General Assembly and 1 member of the general public,
| ||||||
| 16 | appointed by the Minority Leader of the Senate; 2 members | ||||||
| 17 | of the General
Assembly and 1 member of the general public, | ||||||
| 18 | appointed by the Speaker of the
House of Representatives; | ||||||
| 19 | and 2 members of the General Assembly and 1 member of
the | ||||||
| 20 | general public, appointed by the Minority Leader of the | ||||||
| 21 | House of
Representatives.
These members shall serve at the | ||||||
| 22 | pleasure of the appointing authority.
| ||||||
| 23 | (2) The Director of Aging or his or her designee.
| ||||||
| |||||||
| |||||||
| 1 | (3) The Director of Revenue or his or her designee.
| ||||||
| 2 | (4) The Director of Healthcare and Family Services or | ||||||
| 3 | his or her designee.
| ||||||
| 4 | (5) The Secretary of Human Services or his or her | ||||||
| 5 | designee.
| ||||||
| 6 | (6) The Director of Public Health or his or her | ||||||
| 7 | designee.
| ||||||
| 8 | (b) Members appointed from the general public shall | ||||||
| 9 | represent the
following associations, organizations, and | ||||||
| 10 | interests: statewide
membership-based senior advocacy | ||||||
| 11 | organizations, pharmaceutical manufacturers,
pharmacists,
| ||||||
| 12 | dispensing pharmacies, physicians, and providers of services | ||||||
| 13 | to senior
citizens.
No single organization may have more than | ||||||
| 14 | one representative appointed as a
member from the general | ||||||
| 15 | public.
| ||||||
| 16 | (c) The President of the Senate and Speaker of the House of
| ||||||
| 17 | Representatives shall each designate one member of the | ||||||
| 18 | Committee to serve as
co-chairs.
| ||||||
| 19 | (d) Committee members shall serve without compensation or
| ||||||
| 20 | reimbursement for expenses.
| ||||||
| 21 | (e) The Committee shall meet at the call of the co-chairs, | ||||||
| 22 | but at
least quarterly.
| ||||||
| 23 | (f) The Committee may conduct public hearings to gather | ||||||
| 24 | testimony
from interested parties regarding pharmaceutical | ||||||
| 25 | assistance for Illinois
seniors, including changes to existing | ||||||
| 26 | and proposed programs.
| ||||||
| |||||||
| |||||||
| 1 | (f-5) The Committee may review federal legislation with | ||||||
| 2 | regard to e-prescribing to determine what provisions, if any, | ||||||
| 3 | would improve health care in Illinois. | ||||||
| 4 | (f-6) The Committee may conduct public hearings to gather | ||||||
| 5 | testimony regarding federal procedure for pandemic | ||||||
| 6 | preparedness and response to determine whether or not the State | ||||||
| 7 | should update its preparedness procedures and tactics. | ||||||
| 8 | (g) The Committee may advise appropriate State agencies | ||||||
| 9 | regarding
the establishment of proposed programs or changes to | ||||||
| 10 | existing programs. The
State agencies shall take into | ||||||
| 11 | consideration any recommendations made by the
Committee.
| ||||||
| 12 | (h) The Committee shall report to the General Assembly and | ||||||
| 13 | the
Governor annually or as it deems necessary regarding | ||||||
| 14 | proposed or recommended
changes to pharmaceutical assistance | ||||||
| 15 | programs that benefit Illinois seniors and
any associated costs | ||||||
| 16 | of those changes.
| ||||||
| 17 | (h-5) The Committee may conduct public hearings to gather | ||||||
| 18 | testimony from interested parties regarding prescription drug | ||||||
| 19 | abuse to determine whether the State should increase penalties | ||||||
| 20 | against those engaged in conduct potentially harmful to | ||||||
| 21 | Illinois residents, particularly those under age 25. In order | ||||||
| 22 | to do this, the Committee may review guidelines from State | ||||||
| 23 | universities addressing prescription drug abuse. | ||||||
| 24 | (i) In the event that a prescription drug benefit is added | ||||||
| 25 | to the federal
Medicare
program, the Committee shall make | ||||||
| 26 | recommendations for the realignment of State-operated senior | ||||||
| |||||||
| |||||||
| 1 | prescription drug programs so
that Illinois residents qualify | ||||||
| 2 | for at least substantially the same level of benefits
available | ||||||
| 3 | to them prior
to implementation of the Medicare prescription | ||||||
| 4 | drug benefit, provided that a resident remains eligible for | ||||||
| 5 | such a State-operated program. The Committee shall report its | ||||||
| 6 | recommendations to the General
Assembly and
the Governor by | ||||||
| 7 | January 1, 2005.
| ||||||
| 8 | (Source: P.A. 95-331, eff. 8-21-07.)
| ||||||
| 9 | Section 99. Effective date. This Act takes effect upon | ||||||
| 10 | becoming law.
| ||||||